Markets:

Overview

News

Currencies

International

Treasuries

Portage Biotech Inc. - Common Stock (NQ:PRTG)

6.810 UNCHANGED

Last Price Updated: 3:59 PM EDT, Sep 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Portage Biotech Inc. - Common Stock

Emerging Tech Quartet – PRSO, LXRX, PRTG, RNAZ – Drive Breakthroughs Across Defense, Obesity, Oncology, and RNA Therapeutics

March 28, 2025

Via AB Newswire

Topics Intellectual Property

“Stocks Under $1 Gaining Momentum: WBUY, KAVL, OMEX, PRTG, RJDG – Driving Innovation, Market Trends, and Growth Potential”

September 18, 2024

Via AB Newswire

Portage Biotech CEO Interview Explains Why His Company Can Be Poised To Break Higher In 2H 2021 (NASDAQ: PRTG)

July 19, 2021

Via AB Newswire

Portage Biotech Added to Russell 2000(R) Index

June 29, 2021

Westport, Connecticut--(Newsfile Corp. - June 29, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology...

Via Newsfile

Portage Biotech Inc. Announces Pricing of Public Offering of 1,000,000 Ordinary Shares

June 24, 2021

Westport, Connecticut--(Newsfile Corp. - June 24, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology...

Via Newsfile

Topics Regulatory Compliance

Portage Biotech Inc. Announces Proposed Offering of Ordinary Shares

June 23, 2021

Westport, Connecticut--(Newsfile Corp. - June 23, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology...

Via Newsfile

Topics Regulatory Compliance

Portage Biotech Highlights Safety and Survival Data from Intensity Therapeutics' IT-01 Study of INT230-6 (PORT-1) at ASCO 2021 Annual Meeting

June 02, 2021

- Data from the IT-01 trial demonstrate the safety of INT230-6...

Via Newsfile

Portage Biotech Announces Voluntary Delisting from the Canadian Securities Exchange

April 16, 2021

Westport, Connecticut--(Newsfile Corp. - April 16, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) (CSE: PBT.U) ("Portage" or the "Company") a...

Via Newsfile

Portage Biotech Highlights First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors

April 08, 2021

- Novel platform allows co-targeting of iNKT cells and tumor antigens...

Via Newsfile

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.